These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

613 related articles for article (PubMed ID: 35728188)

  • 21. Effect of COVID-19 vaccination and booster on maternal-fetal outcomes: a retrospective cohort study.
    Piekos SN; Hwang YM; Roper RT; Sorensen T; Price ND; Hood L; Hadlock JJ
    Lancet Digit Health; 2023 Sep; 5(9):e594-e606. PubMed ID: 37537121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Humoral Response in Hemodialysis Patients Following COVID-19 Vaccination and Breakthrough Infections during Delta and Omicron Variant Predominance.
    Chinnadurai R; Wu HHL; Cox E; Moore J; Clough T; Lamerton E; Donne R; O'Riordan E; Poulikakos D
    Vaccines (Basel); 2022 Mar; 10(4):. PubMed ID: 35455248
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The displacement of the SARS-CoV-2 variant Delta with Omicron: An investigation of hospital admissions and upper respiratory viral loads.
    Fall A; Eldesouki RE; Sachithanandham J; Morris CP; Norton JM; Gaston DC; Forman M; Abdullah O; Gallagher N; Li M; Swanson NJ; Pekosz A; Klein EY; Mostafa HH
    EBioMedicine; 2022 May; 79():104008. PubMed ID: 35460989
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022.
    Thompson MG; Natarajan K; Irving SA; Rowley EA; Griggs EP; Gaglani M; Klein NP; Grannis SJ; DeSilva MB; Stenehjem E; Reese SE; Dickerson M; Naleway AL; Han J; Konatham D; McEvoy C; Rao S; Dixon BE; Dascomb K; Lewis N; Levy ME; Patel P; Liao IC; Kharbanda AB; Barron MA; Fadel WF; Grisel N; Goddard K; Yang DH; Wondimu MH; Murthy K; Valvi NR; Arndorfer J; Fireman B; Dunne MM; Embi P; Azziz-Baumgartner E; Zerbo O; Bozio CH; Reynolds S; Ferdinands J; Williams J; Link-Gelles R; Schrag SJ; Verani JR; Ball S; Ong TC
    MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(4):139-145. PubMed ID: 35085224
    [TBL] [Abstract][Full Text] [Related]  

  • 25. COVID-19-Associated Hospitalizations Among Adults During SARS-CoV-2 Delta and Omicron Variant Predominance, by Race/Ethnicity and Vaccination Status - COVID-NET, 14 States, July 2021-January 2022.
    Taylor CA; Whitaker M; Anglin O; Milucky J; Patel K; Pham H; Chai SJ; Alden NB; Yousey-Hindes K; Anderson EJ; Teno K; Reeg L; Como-Sabetti K; Bleecker M; Barney G; Bennett NM; Billing LM; Sutton M; Talbot HK; McCaffrey K; Havers FP;
    MMWR Morb Mortal Wkly Rep; 2022 Mar; 71(12):466-473. PubMed ID: 35324880
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Favorable outcomes of COVID-19 in vaccinated hematopoietic stem cell transplant recipients: A single-center experience.
    Tan JY; Wee LE; Tan YH; Conceicao EP; Lim FWI; Chen Y; Than H; Quek JKS; Nagarajan C; Goh YT; Hwang WYK; Phua GC; Chung SJ; Tan TT; Linn YC; Ho AYL; Tan BH
    Transpl Infect Dis; 2023 Jun; 25(3):e14024. PubMed ID: 36715661
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022.
    Modes ME; Directo MP; Melgar M; Johnson LR; Yang H; Chaudhary P; Bartolini S; Kho N; Noble PW; Isonaka S; Chen P
    MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(6):217-223. PubMed ID: 35143466
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Post-vaccination infection rates and modification of COVID-19 symptoms in vaccinated UK school-aged children and adolescents: A prospective longitudinal cohort study.
    Molteni E; Canas LS; Kläser K; Deng J; Bhopal SS; Hughes RC; Chen L; Murray B; Kerfoot E; Antonelli M; Sudre CH; Pujol JC; Polidori L; May A; Hammers PA; Wolf J; Spector PTD; Steves CJ; Ourselin PS; Absoud M; Modat M; Duncan PEL
    Lancet Reg Health Eur; 2022 Aug; 19():100429. PubMed ID: 35821715
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapid emergence of SARS-CoV-2 Omicron variant is associated with an infection advantage over Delta in vaccinated persons.
    Chaguza C; Coppi A; Earnest R; Ferguson D; Kerantzas N; Warner F; Young HP; Breban MI; Billig K; Koch RT; Pham K; Kalinich CC; Ott IM; Fauver JR; Hahn AM; Tikhonova IR; Castaldi C; De Kumar B; Pettker CM; Warren JL; Weinberger DM; Landry ML; Peaper DR; Schulz W; Vogels CBF; Grubaugh ND
    Med; 2022 May; 3(5):325-334.e4. PubMed ID: 35399324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SARS-CoV-2 Vaccine Breakthrough by Omicron and Delta Variants, New York, USA.
    Keyel AC; Russell A; Plitnick J; Rowlands JV; Lamson DM; Rosenberg E; St George K
    Emerg Infect Dis; 2022 Oct; 28(10):1990-1998. PubMed ID: 36048774
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Imaging Severity COVID-19 Assessment in Vaccinated and Unvaccinated Patients: Comparison of the Different Variants in a High Volume Italian Reference Center.
    Granata V; Fusco R; Villanacci A; Magliocchetti S; Urraro F; Tetaj N; Marchioni L; Albarello F; Campioni P; Cristofaro M; Di Stefano F; Fusco N; Petrone A; Schininà V; Grassi F; Girardi E; Ianniello S
    J Pers Med; 2022 Jun; 12(6):. PubMed ID: 35743740
    [TBL] [Abstract][Full Text] [Related]  

  • 32. COVID-19 in non-hospitalised adults caused by either SARS-CoV-2 sub-variants Omicron BA.1, BA.2, BA.4/5 or Delta associates with similar illness duration, symptom severity and viral kinetics, irrespective of vaccination history.
    Townsley H; Gahir J; Russell TW; Greenwood D; Carr EJ; Dyke M; Adams L; Miah M; Clayton B; Smith C; Miranda M; Mears HV; Bailey C; Black JRM; Fowler AS; Crawford M; Wilkinson K; Hutchinson M; Harvey R; O'Reilly N; Kelly G; Goldstone R; Beale R; Papineni P; Corrah T; Gilson R; Caidan S; Nicod J; Gamblin S; Kassiotis G; Libri V; Williams B; Gandhi S; Kucharski AJ; Swanton C; Bauer DLV; Wall EC
    PLoS One; 2024; 19(3):e0294897. PubMed ID: 38512960
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transmission potential of vaccinated and unvaccinated persons infected with the SARS-CoV-2 Delta variant in a federal prison, July-August 2021.
    Salvatore PP; Lee CC; Sleweon S; McCormick DW; Nicolae L; Knipe K; Dixon T; Banta R; Ogle I; Young C; Dusseau C; Salmonson S; Ogden C; Godwin E; Ballom T; Rhodes T; Wynn NT; David E; Bessey TK; Kim G; Suppiah S; Tamin A; Harcourt JL; Sheth M; Lowe L; Browne H; Tate JE; Kirking HL; Hagan LM
    Vaccine; 2023 Mar; 41(11):1808-1818. PubMed ID: 36572604
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical Severity and mRNA Vaccine Effectiveness for Omicron, Delta, and Alpha SARS-CoV-2 Variants in the United States: A Prospective Observational Study.
    Lauring AS; Tenforde MW; Chappell JD; Gaglani M; Ginde AA; McNeal T; Ghamande S; Douin DJ; Talbot HK; Casey JD; Mohr NM; Zepeski A; Shapiro NI; Gibbs KW; Files DC; Hager DN; Shehu A; Prekker ME; Erickson HL; Exline MC; Gong MN; Mohamed A; Johnson NJ; Srinivasan V; Steingrub JS; Peltan ID; Brown SM; Martin ET; Monto AS; Khan A; Hough CL; Busse LW; Ten Lohuis CC; Duggal A; Wilson JG; Gordon AJ; Qadir N; Chang SY; Mallow C; Rivas C; Babcock HM; Kwon JH; Halasa N; Grijalva CG; Rice TW; Stubblefield WB; Baughman A; Womack KN; Rhoads JP; Lindsell CJ; Hart KW; Zhu Y; Adams K; Schrag SJ; Olson SM; Kobayashi M; Verani JR; Patel MM; Self WH;
    medRxiv; 2022 Feb; ():. PubMed ID: 35169811
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Post COVID-19 condition after Wildtype, Delta, and Omicron SARS-CoV-2 infection and prior vaccination: Pooled analysis of two population-based cohorts.
    Ballouz T; Menges D; Kaufmann M; Amati R; Frei A; von Wyl V; Fehr JS; Albanese E; Puhan MA
    PLoS One; 2023; 18(2):e0281429. PubMed ID: 36812215
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neutralizing antibody responses in vaccinated and unvaccinated individuals infected with Omicron BA.1 variant.
    Oh SJ; O SW; Choi YJ; Kim JM; Kim D; Kim IH; Park AK; Kim HM; Rhee JE; Jang YR; Yoo CK; Kim JY; Kim EJ
    J Clin Virol; 2022 Oct; 155():105253. PubMed ID: 35988369
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Breakthrough cases of Omicron and Delta variants of SARS-CoV-2 during the fifth wave in Pakistan.
    Jamal Z; Haider M; Ikram A; Salman M; Rana MS; Rehman Z; Haider SA; Ammar M; Nisar N; Umair M
    Front Public Health; 2022; 10():987452. PubMed ID: 36249252
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Nationwide Cohort Study of Delta and Omicron SARS-CoV-2 Outcomes in Vaccinated Individuals With Chronic Lung Disease.
    Wee LE; Tan JYJ; Chiew CJ; Abisheganaden JA; Chotirmall SH; Lye DCB; Tan KB
    Chest; 2024 Oct; 166(4):685-696. PubMed ID: 38871281
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SARS-CoV-2 Secondary Attack Rates in Vaccinated and Unvaccinated Household Contacts during Replacement of Delta with Omicron Variant, Spain.
    López-Muñoz I; Torrella A; Pérez-Quílez O; Castillo-Zuza A; Martró E; Bordoy AE; Saludes V; Blanco I; Soldevila L; Estrada O; Valerio L; Roure S; Vallès X
    Emerg Infect Dis; 2022 Oct; 28(10):1999-2008. PubMed ID: 36037811
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of vaccines on clinical characteristics of convalescent adult patients infected with SARS-CoV-2 Omicron variant: A retrospective study.
    Wang J; Dong H; Zhao J; Li T; Wang M; Zhou C; Mu H
    Front Microbiol; 2023; 14():1096022. PubMed ID: 37065120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.